Cat.No. | Product Name | Information | Area |
---|---|---|---|
T3530 | Otenabant | Otenabant has been investigated for the treatment of Obesity. | Obesity |
T4654 | SLV319 | SLV319 has been used in trials studying the treatment of Obesity and Obesity and Type... | Obesity |
T4453 | JD-5037 | JD-5037 is a novel, peripherally restricted CB1R antagonist with an IC50 of 1.5 nM. | Endocrine metabolic disease;Diabetes mellitus; Hyperlipidaem |
T9114 | β-Caryophyllene | β-Caryophyllene is a CB2 receptor agonist. | |
T3584 | JWH-133 | JWH 133 is a potent CB2 selective agonist. | Others |
T3699 | Bay 59-3074 | Bay 59-3074 is a CB1/CB2?receptor partial agonist (Ki: 48.3/45.5 nM). In rat model... |
|
T6755 | AM1241 | AM-1241 is a selective cannabinoid CB2 receptor agonist with Ki of 3.4 nM, exhibits 8... | Others |
T1796 | Otenabant hydrochloride | Otenabant hydrochloride (CP-945598) is a competitive, high affinity, selective antago... | Other |
T6417 | BML-190 | BML-190 is a specific CB2 receptor inverse agonist (Ki: 435 nM), with 50-fold selecti... | Nervous system |
T6527 | GW842166X | GW842166X is a potent and highly selective agonist of cannabinoid receptor CB2 recept... | Nervous system |
T2635 | Org 27569 | Org 27569, an allosteric modulator of cannabinoid CB1 receptor, can induce a CB1 rece... | Endocrine system |
T1915 | AM251 | AM251 is a effective CB1 receptor antagonist (IC50/Ki: 8 /7.49 nM) that displays 306-... | Other |
T1519L | Rimonabant | Rimonabant is an inverse agonist for the cannabinoid receptor CB1. It is an anorectic... | Metabolism system |
T1519 | Rimonabant hydrochloride | Rimonabant hydrochloride is a cannabinoid receptor antagonist, binding selectively to... | Metabolism system |